Call for Balancing the Risks and Benefits of Immunotherapeutic Agents for Lymphoma during the COVID-19 Pandemic.
作者信息
Lee Chan Mi, Park Wan Beom
机构信息
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Infect Chemother. 2024 Sep;56(3):406-408. doi: 10.3947/ic.2024.0105.
Abstract
摘要
相似文献
1
Call for Balancing the Risks and Benefits of Immunotherapeutic Agents for Lymphoma during the COVID-19 Pandemic.呼吁在2019冠状病毒病大流行期间平衡淋巴瘤免疫治疗药物的风险与益处
Infect Chemother. 2024 Sep;56(3):406-408. doi: 10.3947/ic.2024.0105.
2
Expanding Youth-Friendly HIV Self-Testing Services During the COVID-19 Pandemic: Qualitative Analysis of a Crowdsourcing Open Call in Nigeria.在新冠疫情期间扩大对青年友好的艾滋病毒自我检测服务：尼日利亚众包公开征集的定性分析
JMIR Form Res. 2024 Apr 30;8:e46945. doi: 10.2196/46945.
3
Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.2019冠状病毒病大流行期间炎症性肠病患者的风险与获益平衡
Gastroenterology. 2021 Jan;160(1):472-473. doi: 10.1053/j.gastro.2020.04.075. Epub 2020 May 15.
4
5
To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic.治疗还是不治疗——权衡2019年冠状病毒病大流行期间癌症患者治疗延迟的利弊
JAMA Oncol. 2020 Dec 1;6(12):1868-1869. doi: 10.1001/jamaoncol.2020.4886.
6
Elective cardiac surgery during the COVID-19 pandemic: Proceed or postpone?COVID-19 大流行期间的择期心脏手术：进行还是推迟？
Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):643-650. doi: 10.1016/j.bpa.2020.07.005. Epub 2020 Jul 18.
7
Preparing for and conducting the National Health and Morbidity Survey in Malaysia amid the COVID-19 pandemic: balancing risks and benefits to participants and society.在 COVID-19 大流行期间筹备和开展马来西亚全国健康和发病率调查：平衡参与者和社会的风险和获益。
Western Pac Surveill Response J. 2021 Sep 3;12(3):71-76. doi: 10.5365/wpsar.2021.12.3.842. eCollection 2021 Jul-Sep.
8
Labor and Delivery Visitor Policies During the COVID-19 Pandemic: Balancing Risks and Benefits.2019冠状病毒病大流行期间的分娩访客政策：权衡风险与益处
JAMA. 2020 Jun 23;323(24):2468-2469. doi: 10.1001/jama.2020.7563.
9
Variation in call volume to the Veterans Crisis Line by women and men veterans prior to and following onset of the COVID-19 pandemic.新冠大流行前后，女性和男性退伍军人拨打退伍军人危机热线的电话量变化。
J Psychiatr Res. 2022 Jul;151:561-563. doi: 10.1016/j.jpsychires.2022.05.037. Epub 2022 May 23.
10
The effect of regional distribution of isolation rooms in emergency departments on ambulance travel time during the COVID-19 pandemic.新冠疫情期间急诊科隔离病房的区域分布对救护车出诊时间的影响。
Clin Exp Emerg Med. 2023 Jun;10(2):191-199. doi: 10.15441/ceem.22.355. Epub 2023 Feb 14.
本文引用的文献
1
The Outcome of SARS-CoV-2 Infection in Patients with Lymphoma and the Risk Factors for the Development of Pneumonia.淋巴瘤患者感染新型冠状病毒2的结局及肺炎发生的危险因素
Infect Chemother. 2024 Sep;56(3):378-385. doi: 10.3947/ic.2024.0046.
2
Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy.T 细胞衔接器对接受 B 细胞耗竭治疗的 B 细胞淋巴瘤患者 COVID-19 相关死亡率的影响。
Cancer Res Treat. 2024 Jan;56(1):324-333. doi: 10.4143/crt.2023.738. Epub 2023 Jul 6.
3
Vaccination Rates of Hospitalized Patients at High Risk of Severe COVID-19: A Single-Center Cross-Sectional Study.新型冠状病毒肺炎重症高危住院患者的疫苗接种率：一项单中心横断面研究
Infect Chemother. 2022 Dec;54(4):787-791. doi: 10.3947/ic.2022.0074.
4
Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients.新诊断慢性淋巴细胞白血病患者低丙种球蛋白血症的患病率及影响
EJHaem. 2020 Sep 1;1(2):537-544. doi: 10.1002/jha2.95. eCollection 2020 Nov.
5
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.BNT162b2 mRNA COVID-19 疫苗在 B 细胞非霍奇金淋巴瘤患者中的疗效。
Blood Adv. 2021 Aug 24;5(16):3053-3061. doi: 10.1182/bloodadvances.2021005094.
6
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.接受B细胞定向疗法的淋巴瘤患者对新冠疫苗接种的体液免疫反应受损。
Blood. 2021 Sep 2;138(9):811-814. doi: 10.1182/blood.2021012443.
7
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.血液系统恶性肿瘤合并 COVID-19 患者的结局：对 3377 例患者的系统评价和荟萃分析。
Blood. 2020 Dec 17;136(25):2881-2892. doi: 10.1182/blood.2020008824.
8
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症：一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
9
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.癌症患者 COVID-19 的患病率和死亡率，以及主要肿瘤亚型和患者人口统计学特征的影响：一项前瞻性队列研究。
Lancet Oncol. 2020 Oct;21(10):1309-1316. doi: 10.1016/S1470-2045(20)30442-3. Epub 2020 Aug 24.
10
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis.利妥昔单抗在淋巴瘤患者维持治疗期间的感染并发症：一项系统评价和荟萃分析。
Leuk Lymphoma. 2009 Mar;50(3):357-65. doi: 10.1080/10428190902730219.
Zotero 插件